Trevi Therapeutics (TRVI) Share-based Compensation (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.30% |
| Dec 31, 2025 | 8.61% |
| Sep 30, 2025 | -10.19% |
| Jun 30, 2025 | 14.57% |
| Mar 31, 2025 | 31.73% |
| Dec 31, 2024 | 11.56% |
| Sep 30, 2024 | -27.06% |
| Jun 30, 2024 | 55.88% |
| Mar 31, 2024 | 35.39% |
| Dec 31, 2023 | 0.75% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -8.30% |
| Mar 31, 2023 | 15.37% |
| Dec 31, 2022 | -11.95% |
| Sep 30, 2022 | 9.42% |
| Jun 30, 2022 | -29.44% |
| Mar 31, 2022 | 36.48% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | -27.52% |
| Jun 30, 2021 | 3.76% |
| Mar 31, 2021 | 40.78% |
| Dec 31, 2020 | -13.27% |
| Sep 30, 2020 | -0.17% |
| Jun 30, 2020 | -19.32% |
| Mar 31, 2020 | 95.71% |
| Dec 31, 2019 | 0.54% |
| Sep 30, 2019 | 56.54% |
| Jun 30, 2019 | 62.33% |
| Mar 31, 2019 | -21.08% |
| Dec 31, 2018 | 52.89% |
| Sep 30, 2018 | 18.63% |
| Jun 30, 2018 | 15.91% |